Secondary preventive medication persistence and adherence 1 year after stroke

Neurology

Volumn 77, Issue 12, 2011, Pages 1182-1190

  Bushnell, C D ^a   Olson, D M ^b   Zhao, X ^b   Pan, W ^b   Zimmer, L O ^b   Goldstein, L B ^c   Alberts, M J ^d   Fagan, S C ^e   Fonarow, G C ^f   Johnston, S C ^g   Kidwell, C ^h   LaBresh, K A ⁱ   Ovbiagele, B ^j   Schwamm, L ^k   Peterson, E D ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ RTI INTERNATIONAL   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; THIAZIDE DIURETIC AGENT; WARFARIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; FEMALE; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HOSPITAL DISCHARGE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY PREVENTION; STROKE; AGED; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; REGISTER;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; REGISTRIES; SECONDARY PREVENTION; STROKE;

EID: 80555156719     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31822f0423     Document Type: Article

References (21)

1. Roger V, Go A, Lloyd-Jones D, et al. Heart disease and stroke statistics 2011 update: a report from the American Heart Association. In: Circulation [serial online] 2010. Available at: http://circ.ahajournals.org. Accessed December 23, 2010.
2. Sacco R, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006;37:577-617.
3. Glader E-V, Sjolander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 2010;41:2552-2558.
4. Shaya F, El Khoury A, Mullins C, et al. Drug therapy persistence and stroke recurrence. Am J Manag Care 2006; 12:313-319.
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497. (Pubitemid 41127293)
6. Bushnell C, Zimmer L, Schwamm L, et al. The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: design, rationale, and baseline patient characteristics. Am Heart J 2009;157:428-435.
7. Cramer J, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-47. (Pubitemid 351160875)
8. Benner J, Glynn R, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288:455-461. (Pubitemid 34787476)
9. The EuroQol Group. EuroQol : a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
10. Kroenke K, Spitzer R. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002;32:1-7.
11. Hankey G, Jamrozik K, Broadhurst R, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998;29:2491-2500. (Pubitemid 28543996)
12. Ovbiagele B, Kidwell C, Selco S, Razinia T, Saver J. Treatment adherence rates one year after initiation of a systematic hospital-based stroke prevention program. Cerebrovasc Dis 2005;20:280-282. (Pubitemid 41318207)
13. Lummis H, Sketris I, Gubitz G, Joffres M, Flowerdew G. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. In: BMC Neurol [serial online] 2008. Available at: http://www.biomedcentral.com. Accessed July 1, 2009.
14. Bushnell C, Zimmer L, Pan W, et al. Persistence with stroke prevention medications 3 months after hospitalization. Arch Neurol 2010;67:1456-1463.
15. Ali R, Melloni C, Ou F-S, et al. Age and persistent use of cardiovascular medication after acute coronary syndrome: results from the Medication Applied and Sustained Over Time. J Am Geriatr Soc 2009;57:1990-1996.
16. Bailey J, Wan J, Tang J, Ghani M, Cushman W. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med 2010; 25:495-503.
17. Gazmararian J, Kripalani S, Miller M, et al. Factors associated with medication refill adherence in cardiovascularrelated diseases: a focus on health literacy. J Gen Intern Med 2006;21:1215-1221. (Pubitemid 44665327)
18. Shaya F, Du D, Gbarayor C, et al. Predictors of compliance with antihypertensive therapy in a high-risk Medicaid population. J Natl Med Assoc 2009;101:34-39.
19. Spertus J, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER Registry. Circulation 2006; 113:2803-2809. (Pubitemid 44305292)
20. Pit S, Byles J, Cockburn J. Accuracy of telephone selfreport of drug use in older people and agreement with pharmaceutical claims data. Drugs Aging 2008;25: 71-80.
21. Otsuki M, Clerisme-Beaty E, Rand C, Riekert K. Measuring adherence to medication regimens in clinical care and research. In: Shumaker S, Ockene J, Riekert K, eds. The Handbook of Health Behavior Change, 3rd ed. New York: Springer; 2009:309-325.